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Abstract Chondroitin 4-sulphate (C4S), a basic component of 
the extracellular matrix of the artery wall, inhibited copper-
induced low density lipoprotein (LDL) oxidation by prolonging 
the lag time and reducing the rate of propagation. LDL oxidation 
was assessed by monitoring conjugated dienes and low level 
chemiluminescence. A possible initial key reaction in LDL 
oxidation, the reduction of copper(II) to copper(I) by LDL, was 
decreased in the presence of C4S. Moreover, C4S protected 
tryptophan residues of Apo-B-100 in the early stage of LDL 
oxidation and during the subsequent propagation phase. The 
presence of the sulphate group in position 4 of ./V-acetylgalacto-
saminyl residues of C4S is crucial for protective activity. In fact, 
the structurally related chondroitin 6-sulphate, also present in 
tissues, had no effect on LDL oxidation. These data suggest that 
C4S may contribute to protect LDL against oxidation in arterial 
intima. 
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1. Introduction 
Several lines of evidence support the hypothesis that oxida-
tion of low density lipoprotein (LDL) may play a crucial role 
in the initiation and progression of atherosclerosis. Oxidized 
LDL is taken up avidly by macrophages via scavenger recep-
tors, leading to foam-cell formation and exhibits also chemo-
tactic, cytotoxic and prothrombotic effects [1,2]. 
It is generally accepted that LDL oxidation may occur in 
arterial intima, which is at least partially segregated from 
plasma antioxidants and metal chelating proteins [1,2]. There-
fore, the oxidative modification of LDL is likely to occur in 
close contact with proteoglycans, a basic component of the 
interfibrillar space. In vascular tissue the most abundant pro-
teoglycan contains a large number of glycosaminoglycan 
(GAG) chains, which are mainly represented by chondroitin 
sulphate (CS) [3,4]. The possibility of a close interaction be-
tween LDL and GAG chains in the extracellular matrix of 
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arterial intima is supported by the observation that such com-
plexes may be formed in vitro [5,6] and can be extracted from 
arterial wall [7]. 
Following these considerations, we investigated whether CS 
might interfere with LDL oxidation. In tissues CS chains are 
prevalently sulphated either in position 4 (C4S) or in position 
6 (C6S) of Af-acetylgalactosaminyl residues [3]. Therefore, 
both polymers were considered in our study. We found that 
only C4S was able to inhibit Cu2+-induced oxidation of LDL, 
indicating that the presence of sulphate groups on C-4 was 
required for the protective properties of the chain. The effect 
of C4S was studied with regard to kinetic parameters of LDL 
oxidation by Cu2+ and to tryptophan (Trp) residues of Apo-
B-100, possibly involved in the initiation phase of LDL oxi-
dation [8]. 
2. Materials and methods 
2.1. Materials 
2,2'-Azobis(2-amidinopropane hydrochloride) (AAPH) was pur-
chased from Polysciences (Warrington, PA). C4S from whale cartilage 
and C6S from shark cartilage were obtained from Seikagaku (Tokyo, 
Japan). The sulphation pattern of the chains was checked by HPLC 
separation of unsaturated disaccharides obtained after chondroitinase 
ABC digestion [9]. The disaccharide compositions (in percentage) 
were: C4S, a-AUA-[l ^ 3]-GalNAc-4S, 82.1; a-AUA-[l ^3]-Gal-
NAc-6S, 17.9; C6S, a-AUA-[l->3]-GalNAc-4S, 15; ex-AUA-[l-> 3]-
GalNAc-6S, 80; a-AUA-2S-[l ^ 3]-GalNAc-4S, 5. Other reagents 
used were of AR grade, obtained from Merck (Darmstadt, Germany) 
or Sigma (St. Louis, MO). 
2.2. Preparation of LDL 
EDTA-plasma (1 mg/ml) was prepared from blood of normolipi-
demic, healthy volunteers of both sexes (age 25-35) after overnight 
fast. Plasma samples were pooled and frozen at —80°C in 0.6% su-
crose for up to 4 weeks. LDL was prepared by ultracentrifugation 
(Beckman L70) in a single step discontinuous gradient using an NVT 
65 rotor (Beckman)[10]. LDL was stored in a vial under argon at 4°C, 
in the dark and used within 1 week after preparation. LDL chemical 
composition was normal according to [2]. 
2.3. LDL oxidation 
Before oxidation, LDL was freed of EDTA by gel filtration with an 
Econo-Pac 10 DG column (BioRad, Hercules, CA) using phosphate-
buffered saline (PBS) as eluent. The composition of PBS was: 10 mM 
sodium phosphate, 150 mM sodium chloride, pH 7.4. LDL concen-
tration in PBS was determined by total cholesterol assay (CHOD-PAP 
kit, Boehringer Mannheim, Germany). Assuming a molecular mass of 
2.5 MDa for LDL and a cholesterol content of 31.6%, a concentration 
of 0.1 uM LDL corresponded to 0.25 mg/ml total mass and 79 ug/ml 
cholesterol [10]. 
0.1 uM LDL, freed of EDTA, was oxidized with CuS04 at 37°C in 
PBS in the absence and presence of CS. Oxidation was followed by 
monitoring the increase in absorbance at 234 nm (^ 234), due to the 
formation of conjugated dienes (CD) from polyunsaturated fatty acids 
[11]. Lag time, maximal rate of propagation and CD concentration 
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were considered as indices of LDL oxidation and determined accord-
ing to [10,11]. 
Alternatively, 0.1 uM LDL, freed of EDTA, was oxidized with 
AAPH in PBS at 37°C. The oxidation was then monitored by record-
ing the increase of ^234. 
2.4. Chemìlumìnescence measurements 
Low level chemiluminescence was measured in a Lucy 1 luminom-
eter (Anthos Labtec Instruments, Salzburg, Austria) equipped with a 
photomultiplier tube (sensitivity ranging from 300 to 700 nm). Inte-
gration time for each data point was set to 60 s. 0.3 uM LDL in PBS 
was oxidized with CUSO4 in the presence of various concentrations of 
CS. The assays were performed at 37°C in a white microplate. 
2.5. Measurement of LDL-Trp fluorescence 
Trp fluorescence was measured in a solution of 0.1 |J.M LDL in PBS 
at 37°C, using a Shimadzu RF 5001 PC fluorometer (emission 331 
nm, excitation 282 nm)[8]. The kinetics of LDL oxidation was fol-
lowed by measuring the decrease of Trp fluorescence, corresponding 
to the decomposition of this amino acid, after addition of 1.6 |xM 
Cu2+, in the absence or presence of CS. The quenching of Trp fluo-
rescence was calculated as percent decrease of LDL-Trp fluorescence 
measured 2 min after Cu2+ addition (1.6 uM, final concentration). 
2.6. Assay of Cu2+ reduction 
The ability of LDL to reduce Cu2+ was assayed using bathocu-
proine, a selective chelator of Cu+ [12]. 0.1 U.M LDL in PBS was 
incubated with 360 |iM bathocuproine at 37°C, in the presence or 
absence of CS. Cu+ concentration was calculated using a calibration 
curve obtained after Cu2+ reduction by 1 mM ascorbate. 
3. Results 
Under our experimental conditions, the profile of CD vs. 
time showed three evident phases, a lag phase, a propagation 
phase and a decomposition phase in agreement with a pre-
vious report [10] (Fig. 1). The addition of C4S at concentra-
tions ranging from 0.2 to 2 mg/ml resulted in a dose-depend-
ent increase of lag phase (Fig. 1). In contrast, C6S was 
completely ineffective at concentrations up to 2 mg/ml (Fig. 
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Fig. 1. C4S effect on the kinetics of copper-induced LDL oxidation. 
0.1 uM LDL in 10 mM PBS was incubated with 1.6 |xM Cu2+ in 
the absence and presence of increasing C4S concentrations, as indi-
cated. CD formation was followed by recording the increase in ab-
sorbance at 234 nm at 37°C. CD concentration was calculated from 
the 2^34 using a molar absorbance of 29500 1 mol-1. Experiments 
performed with copper concentrations ranging from 0.8 to 4 uM 
confirmed the ability of C4S to prolong the lag phase. Inset: C6S 
effect on the kinetics of copper-induced LDL oxidation. LDL was 
oxidized in the absence (continuous line) and presence of C6S con-
centrations up to 2 mg/ml (dotted line). 
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Fig. 2. (A) C4S effect on lag time during copper-induced LDL oxi-
dation. Lag time was graphically determined from CD vs. time pro-
files of Fig. 1A, as the intercept of the tangents to the slow and fast 
increase of diene absorption [11]. Values are means ± S.D. of 4 dif-
ferent experiments. The line was drawn by linear regression analysis. 
(B) C4S effect on maximum rate of propagation during copper-
mediated LDL oxidation. Maximum rate of propagation (VmS5L) was 
expressed as A 2^34/min and was determined as the peak value of 
the first derivative of CD vs. time profiles reported in Fig. 1 [11]. 
Values are means ± S.D. of 4 different experiments. The line was 
drawn by non-linear regression analysis. 
1, inset). The plot of lag time vs. C4S concentration showed a 
linear relationship (Fig. 2A). C4S also reduced the maximum 
rate of LDL oxidation (Kmax), expressed as A^234/min; the 
plot of rate against C4S concentration resulted in a non-linear 
relationship (Fig. 2B). The different effect of C4S on lag time 
and Fmax might depend on the different chemical processes 
operating during the lag phase and propagation phase. C4S 
was not able to modify the value of total CD production at 
the end of the propagation phase, which was 24 ± 1 |o.M, in-
dicating a high level of oxidation (Fig. 1). The ability of C4S 
to prolong the lag time and to reduce P"max showed that it was 
effective as an inhibitor of the oxidation process. 
The protective effect of C4S was confirmed when the oxi-
dation of LDL was assayed by monitoring chemiluminescence 
associated with the lipid peroxidation process [13]. As in the 
case of the CD profile, the time course of chemiluminescence 
was characterized by a lag phase and by a phase with a rapid 
increase in light emission (Fig. 3A,B). Addition of C4S in the 
incubation mixture induced prolongation of the lag phase 
(Fig. 3A,B). C6S was again ineffective, as shown in the CD 
assay. 
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Fig. 3. Monitoring of LDL oxidation by low-level chemilumines-
cence. The emission of light is expressed in counts per min (cpm). 
0.3 uM LDL was incubated at 37°C in the absence (continuous 
line) and presence of 1 mg/ml C4S (dotted line) and 1 mg/ml C6S 
(dashed line) at Cu2+ concentration of 1.48 uM (A) and 0.74 uM 
(B). Experiments performed with different copper concentrations 
(ranging from 0.74 to 4 uM Cu2+) confirmed the protective role of 
C4S and the inefficiency of C6S. 
not able to modify the time course of Trp fluorescence loss 
(Fig. 4B). 
It has been suggested that the reduction of Cu2+ to Cu+ 
might represent a rate-limiting step of LDL oxidation [2]. The 
formation of Cu+ by LDL, in the presence and absence of CS, 
was assayed according to [12]. The addition of 2 mg/ml C4S 
to an incubation mixture containing 0.1 uM LDL and 30 uM 
Cu2+ induced the following effects: (1) it reduced the amount 
of Cu+ formed after 10 min of incubation from 14.5±0.5 to 
10 ±0.4 uM; and (2) it decreased the maximum rate of Cu+ 
formation from 2 ±0.03 to 1.3 ±0.03 uM/min. These data in-
dicate that C4S reduced the formation of Cu+ , that is gener-
ally considered as the prooxidant form of copper. In contrast, 
C6S did not affect Cu2+ reduction by LDL. 
The formation of a stable redox inactive complex between 
C4S and copper might be a possible molecular mechanism 
responsible for the protective effect of C4S on LDL oxidation. 
To test this hypothesis, we used the experimental approach 
that is based on the degradation of ascorbic acid by Cu2+ [14]. 
In this reaction, ascorbic acid is both the reductant of Cu2+ 
and the target of Cu+. C4S did not inhibit the degradation of 
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The effect of CS on some indices of the protein moiety of 
LDL during oxidation was also investigated. The degradation 
of a proportion of Trp residues of Apo-B-100 is an early event 
during Cu2+-mediated oxidation of LDL, resulting from a 
lipid peroxidation independent process [8]. The addition of 
1.6 uM Cu2+ caused a quenching effect on Trp fluorescence 
(resulting from Cu2+ complexation by Trp residues) of 11% in 
the control and of 5.6% in the presence of C4S (Fig. 4A). 
Since Apo-B-100 contains 37 Trp residues, each proportion-
ally contributing to the total fluorescence emission, it can be 
deduced that about 4 Trp residues for the LDL particle are 
immediately accessible to copper ions; this value is reduced to 
1.7 in the presence of C4S. This observation suggests that C4S 
protects Trp residues probably involved in the initiation proc-
ess. In contrast, C6S had no influence on Trp quenching by 
copper (Fig. 4A). 
The loss of Trp fluorescence during LDL oxidation was 
monitored with increasing time (Fig. 4B). We identified a 
lag phase, characterized by a low decrease in fluorescence 
emission, that was substituted by a fast decrease (presumably 
resulting from interaction of Trp with oxidizing lipids) after 
about 80 min in the control. The addition of C4S prolonged 
the lag phase of Trp destruction to 150 min, whereas C6S was 
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Fig. 4. (A) Effect of chondroitin sulphate on copper-induced Trp 
quenching. Trp fluorescence (excitation, 282 nm; emission, 331 nm) 
of 0.1 uM LDL in PBS was measured before and 2 min after addi-
tion of 1.6 uM Cu2+ in PBS at 37°C, in the absence (control) and 
presence of 1 mg/ml of C4S and C6S. The drop in fluorescence is 
expressed as percent decrease. (B) Kinetics of Trp fluorescence de-
crease during copper-mediated oxidation of LDL. LDL was oxi-
dized in the absence (continuous line) and presence of C4S (dotted 
line) and C6S (dashed line). Experimental conditions were the same 
as described in (A). 
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Fig. 5. (A) Effect of C4S on copper-catalyzed oxidation of ascor-
bate. 0.1 mM ascorbate was incubated in PBS at 37°C with Cu2+ 
(0.25 and 0.5 uM) in the absence (continuous line) or presence of 
1 mg/ml C4S (dotted line). Ascorbate oxidation was monitored by 
the decrease of A2 . (B) Effect of C4S on AAPH-induced LDL oxi-
dation. 0.1 uM LDL was incubated with 1 mM AAPH at 37°C in 
PBS in the absence (continuous line) and presence of 1 mg/ml C4S 
(dotted line). LDL oxidation was followed by monitoring CD for-
mation as the increase in A2u- Experiments performed with different 
AAPH concentrations (ranging from 1 to 3 mM) gave similar re-
sults. 
0.1 mM ascorbic acid, indicating that it did not form redox 
inactive complexes with copper ions (Fig. 5A). 
Finally, the possibility that C4S may also modulate the 
oxidation of LDL induced by a metal independent agent 
was investigated. LDL was exposed to AAPH, a generator 
of aqueous peroxyl radicals [2]. C4S did not affect the CD 
vs. time profile, indicating that it was ineffective against per-
oxyl-mediated LDL oxidation (Fig. 5B). 
4. Discussion 
Our results demonstrate that C4S exhibited a protective role 
during in vitro LDL oxidation by copper ions, whereas it was 
ineffective in a model of metal independent oxidation. In con-
trast, C6S lacked any effect on all the considered indices of 
LDL oxidation. 
The sulphation pattern of CS in tissues is the result of a 
controlled metabolic activity [15] and involves important bio-
logical implications. In particular, in human aorta the relative 
content of C4S varies with age; the C4S/C6S ratio decreases 
from approx. 1 in young individuals (4 months to 5 years age) 
to 0.5-0.4 in adult age [16]. The loss of C4S and concomitant 
increase of C6S is even more pronounced in atherosclerotic 
lesions (C4S/C6S ratio 0.2 ± 0.05) [16]. Our results suggest that 
the modification of GAG content induced by age and athero-
sclerosis, consisting of a decrease of C4S with protective ac-
tivity, may increase the susceptibility of LDL to oxidation. 
Moreover, the proportion of C4S in different vascular districts 
(pulmonary artery, iliac artery, aorta) decreases in an order 
corresponding to increasing risk for atherosclerosis [17]; this 
may at least partially depend on the different ability of the 
two isomers to protect LDL against metal dependent oxida-
tive stress. The possible biologic relevance of our study is 
supported by the use of CS at concentration comparable to 
that found in vascular tissue [4,16] and by the fact that copper 
ions are possibly involved to a certain extent in LDL oxida-
tion in vivo [18]. 
The decrease of Trp quenching by Cu2+ and the lowering of 
Cu+ formation indicate that C4S is effective in the early stage 
of LDL oxidation. These data, as well as the increase in the 
lag phase, suggest a reduction of the initiation rate in the 
presence of C4S. Radical scavenging properties of C4S are 
unlikely to be involved, as it was unable to inhibit peroxyl-
mediated LDL oxidation. 
According to several authors [2,8,14], part of the copper 
binding sites involved in the initiation of LDL oxidation 
might be located on Apo-B-100. Therefore, it seems reason-
able to admit that a specific conformation of Apo-B-100 is 
important during the initiation phase. Under experimental 
conditions comparable to ours, an ionic interaction between 
the positively charged amino acids of Apo-B-100 and nega-
tively charged GAGs has been described and shown to be 
dependent on their sulphation pattern [5,6]. Following these 
considerations, we suggest that C4S may interfere with LDL 
oxidation by covering or masking some copper binding sites 
on Apo-B-100, as a result of its interaction with the particle. 
C6S may be unable to realize a similar interaction, owing to 
the different position of the sulphate group, outside the sugar 
ring. 
Finally, our results are compatible with the hypothesis that 
C4S and, possibly, other GAGs, may form a diffuse net in the 
extracellular matrix and in the pericellular environment, con-
tributing to the protection of lipoproteins moving from intra-
vascular compartment to arterial wall against some types of 
oxidative damage. 
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